Abstract
This editorial is focused on the double controversial action of erythropoietin, acting as anticancer agent and as a promoting cancer agent.
| Original language | English |
|---|---|
| Pages (from-to) | 1-4 |
| Number of pages | 4 |
| Journal | Leukemia Research |
| Volume | 33 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jan 2009 |
Keywords
- Erythropoietin
- Erythropoietin receptor
- Erythropoietin-stimulating agents
- Tumor progression
ASJC Scopus subject areas
- Cancer Research
- Hematology
- Oncology
Fingerprint Dive into the research topics of 'Erythropoietin and cancer, a double-edged sword'. Together they form a unique fingerprint.
Cite this
Ribatti, D. (2009). Erythropoietin and cancer, a double-edged sword. Leukemia Research, 33(1), 1-4. https://doi.org/10.1016/j.leukres.2008.06.004